Jolene Bressi, PhamD, PMP, BCMAS

The drug may be a risk factor for dementia-related illnesses.

The safety and efficacy of long-term benzodiazepine use beyond the recommended timeframe is not well understood.

Misconceptions about the diagnosis of attention-deficit hyperactivity disorder reduce the credibility of health care providers and delay or prevent treatment for patients suffering from this condition.